3,4-Methylenedioxy-N-hydroxyamphetamine

MDOH
Clinical data
Other names	MDOH; MDH; N-Hydroxy-MDA
Routes of; administration	Oral
Drug class	Serotonergic psychedelic; Hallucinogen; Entactogen
ATC code	None;
Legal status
Legal status	CA: Schedule I; DE: Anlage I (Authorized scientific use only); UK: Class A; US: Schedule I; UN: Psychotropic Schedule I;
Pharmacokinetic data
Duration of action	3–6 hours
Identifiers
	IUPAC name N-[1-(1,3-benzodioxol-5-yl)propan-2-yl]hydroxylamine;
CAS Number	74698-47-8;
PubChem CID	98528;
ChemSpider	88979;
UNII	SJE1T2B1A7;
KEGG	C22807;
CompTox Dashboard (EPA)	DTXSID30860972 ;
Chemical and physical data
Formula	C10H13NO3
Molar mass	195.218 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(CC1=CC2=C(C=C1)OCO2)NO;
	InChI InChI=1S/C10H13NO3/c1-7(11-12)4-8-2-3-9-10(5-8)14-6-13-9/h2-3,5,7,11-12H,4,6H2,1H3; Key:FNDCTJYFKOQGTL-UHFFFAOYSA-N;

3,4-Methylenedioxy-N-hydroxyamphetamine (MDOH, MDH), also known as N-hydroxy-MDA, is an entactogen, psychedelic, and stimulant of the phenethylamine, amphetamine, and MDxx families. It is the N-hydroxy homologue of MDA, and the N-desmethyl homologue of FLEA (MDMOH).